An FDA advisory panel voted 7-6 that the benefits of Corvane’s veltisiran outweigh its risks. Several members said the trial left out the patients most likely to use it.
A bipartisan Senate bill would limit what hospital outpatient departments can charge for infusion drugs to what a doctor’s office is paid. Hospitals say it would close clinics.
A new payment rule will cover home devices that track heart failure patients between visits. Doctors like the idea and worry about who reads the data.
At least 11 states are weighing bills on software that listens to doctor visits and writes the notes. Most would require patients to be told, and some to say yes.
